Fellow-eye Study (FE) of LX101 in Subjects With Inherited Retinal Dystrophy
Clinical trial NCT06212297 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06212297
- Sponsor
- Innostellar Biotherapeutics Co.,Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-12
- Primary completion
- 2025-02-06
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.